31 computer-programmer-"EPIC" Postdoctoral positions at University College Cork in Ireland
Sort by
Refine Your Search
-
national datasets. The candidate will also work with an experienced team of collaborators in synthesising the findings of the research programme overall, and in communication of study findings to a broad
-
meaningful public and patient involvement in health and social care research. The successful candidate will work closely with our Programme Manager and collaborate with a national team including Programme
-
Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No Offer Description Position Summary Can you make an invaluable contribution
-
at the core of the work: soundscape ecology of underwater recordings, and document analysis. The nature and structure of the Phase 2 Research Ireland Centre programme allows for Post-Doctoral Researchers
-
several projects in the centre including the MAGICA project ( https://magica-project.eu/), a landmark initiative funded under EU Horizon programme. The MAGICA project aims to accelerate the development
-
programmes in Engineering and Commerce, with an FTE of 800+ attributed to the school. At postgraduate level, the School runs three successful master’s degrees in financial and computational mathematics
-
an established group of researchers. The nature and structure of the Phase 2 Research Ireland Centre programme allows for Post-Doctoral Researchers to work and gain valuable experience in a varied & research-rich
-
for this position. This is an advanced research training role, building on their prior experience as a Post-Doctoral Researcher in UCC or elsewhere, where you will conduct a specified programme of research and
-
cancers and inflammatory conditions. The research project is supported by a Research Ireland-funded Frontiers for the Future Award programme. We are seeking highly motivated candidates with a PhD and
-
BACtheWINNER team. The main aim of this research programme is to develop bacteriocins as novel antimicrobials/therapeutics by solving the current challenges associated with their implementation, such as low